Infusion therapy refers to the administration of medications through needles and catheters. These procedures are usually performed when oral medication treatments are not effective on the patients. Home infusion therapies are those infusion therapies that can be taken by the patient at home, upon prescription by a physician. Home infusion therapies are taken either through intravenous (IV) routes into the bloodstream or a tube placed in the patient’s intestine or stomach.
Various drug therapies are performed at home including pain management, parenteral nutrition, antibiotics and IVIG therapy. In addition, insulin home infusion therapy is also performed; it is the most widely used home infusion therapy. Pain killers and IVIG account for the major market shares after insulin. IVIG can be allowed to be administered to a patient after the diagnosis of congestive heart failure, neurological disorders and immune disorders. Home infusion therapy requires administrative services, pharmacy services, patient educating and training, equipments, care coordination and supplies.
Change in lifestyle will boost the growth of home infusion therapy market. In addition, increase in diabetic population and reduction in treatment cost will also trigger the growth of this market. Many complicated medical conditions and illnesses can be treated with these infusion therapies which will reduce the hospital stay, and hence reduce the cost of treatment as well. Home infusion therapies are safer since the administration of the drugs is observed by physicians. This will also augment the growth of this market. Reimbursement policies of various public and private firms will also boost the growth of this market.
Despite all these, sometimes overdosage of medications may cause hazardous conditions which may hinder the growth of this market. The major players operating in this market include Abbott Laboratories, Stryker Corporation, Continuum Rx, Bristol-Myers Squibb, and Eli Lilly and Company, among other significant players.
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453